Canping Chen
机构：Oregon Health & Science University, Columbia University · ORCID：0000-0003-4021-8592
发表论文 137 篇 · 总被引 393 次 · h-index 11
代表论文
- Combined BET bromodomain and DNMT inhibition targets critical survival pathways in transdifferentiated prostate cancer (2026 · JCI Insight)
- Supplementary Table S2 from scSurvival: Single-Cell Survival Analysis of Clinical Cancer Cohort Data at Cellular Resolution (2026)
- Figure 2 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
- Supplementary Table S4 from scSurvival: Single-Cell Survival Analysis of Clinical Cancer Cohort Data at Cellular Resolution (2026)
- Supplementary Figure S8 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
- Supplementary Data 3 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)